Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0FVKRE
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
DM003
|
|||||
| Synonyms |
DM-003; DM 003
Click to Show/Hide
|
|||||
| Organization |
Doma Biopharmaceutical (Suzhou) Co., Ltd.; Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 1 Indication(s)
Solid tumors [ICD11:2A00-2A0Z|2B50-2F9Z]
Clinical candidate
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Inactive tyrosine-protein kinase 7 (PTK7); Epidermal growth factor receptor (EGFR)
|
Antigen Info | ||||
| Payload Name |
Monomethyl auristatin E
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.